India urged to expand local vaccine manufacturing and research: GTRI

  • Articles
  • Nov 12,24
The think tank recommended that the Indian government investigate all adverse health events post-vaccination.
India urged to expand local vaccine manufacturing and research: GTRI

India should focus on expanding its local vaccine manufacturing and research capabilities to enhance control over the safety and effectiveness of pharmaceutical products, according to a report by the Global Trade Research Initiative (GTRI).

The think tank recommended that the Indian government investigate all adverse health events post-vaccination. This step, it suggests, could improve the transparency, safety, and efficacy of future vaccine rollouts.

“Expanding local vaccine production and research will enable India to better address vaccine safety, ensuring that vaccines are tailored to the country's specific health needs and population characteristics,” the report stated.

This call for expansion gains further relevance following the release of The Pfizer Papers: Crimes Against Humanity in October 2024, which has sparked global debate on vaccine safety, ethics, and transparency.

Ajay Srivastava, Founder, GTRI, emphasised, “As the world prepares for future pandemics, insights from The Pfizer Papers can lay the groundwork for safer, more effective, and more trustworthy vaccination strategies, prioritising public health over profit in global health responses.”
(Business Standard)

Related Stories

Policy Regulation
Port delays and regulations strain India’s steel user industries: GTRI

Port delays and regulations strain India’s steel user industries: GTRI

Policies designed to protect domestic steelmakers, such as import restrictions and quality control measures, have inadvertently hurt industries dependent on imported steel, undermining their product..

Read more
Process Equipment
AptarGroup breaks ground on new pharma plant in Taloja, near Mumbai

AptarGroup breaks ground on new pharma plant in Taloja, near Mumbai

Spanning 4,400 square metres, the new plant will be constructed adjacent to Aptar's existing Mumbai facility, which opened in 2023.

Read more
Process Equipment
India urged to expand local vaccine manufacturing and research: GTRI

India urged to expand local vaccine manufacturing and research: GTRI

The think tank recommended that the Indian government investigate all adverse health events post-vaccination.

Read more

Related Products

Programmable Controllers - Pcd-33a Series

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Pro-Med Instruments (P) Ltd offers a wide range of programmable controllers - PCD-33A Series.


Read more

Request a Quote

Gasket Graphite Powder

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Arihant Packing & Gasket Company offers a wide range of gasket graphite powder. 


Read more

Request a Quote

Asahi Kasei expands 3D printing filament sales in North America

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Asahi Kasei, a leading resin and compounding technology provider, has initiated the sales of 3D printing (3DP) filaments in North America through Asahi Kasei Plastics North America (APNA). The soft la Read more

Request a Quote

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016